期刊文献+

分子对接虚拟筛选六味地黄方中α-葡萄糖苷酶抑制剂 被引量:6

Virtual Screening of Active α-Glucosidase Inhibitors from Liuwei Dihuang Prescription Using Molecular Docking
原文传递
导出
摘要 目的:传统名方六味地黄方(LWDH)对治疗2型糖尿病具有较好疗效,α-葡萄糖苷酶(α-GC)是2型糖尿病发生发展的关键靶点,该文采用虚拟筛选技术分析LWDH中抑制α-GC活性的有效成分。方法:从文献中获取LWDH中己知的21种主要化学成分及代谢产物结构组成配体分子库,采用分子对接法将配体与α-GC的C端,N端分别逐一对接后,进行复合物自由结合能的数据分析;并以α-GC抑制剂阿卡波糖(ACR)的结合能作为阈值,预测LWDH中抑制α-GC活性潜在的有效成分。结果:与ACR和α-GC之N端,C端的结合能(-38.38,-36.38 J·mol-1)相比较,分别有2种LWDH的主要成分与α-GC的N端或C端结合能较低,其作用力主要为氢键和范德华力,且这几种成分均属于组成药物泽泻中的四环三萜类化合物。结论:基于分子对接的虚拟筛选可推断LWDH中抑制α-葡萄糖苷酶活性的有效物质,为深入开展六味地黄方治疗2型糖尿病的机理研究提供了科学数据。 Traditional famous prescription Liuwei Dihuang prescription( LWDH) has a good effect in treating type 2 diabetes. α-Glucosidase( α-GC) is the key target of development of type 2 diabetes. In this paper,we analyzed active α-GC inhibitors from LWDH by using virtual screening technique. Method: We obtained structures of 21 known main chemical components and metabolites in LWDH from literatures to compose the molecular ligand library. Ligands were combined with α-GC at terminal N and terminal C by using molecular docking. After docking,the lowest binding energy( LBE) of the complexes was calculated to predict potential active α-GC inhibitors,with LBEs of α-GC inhibitor acarbose( ACR) as the threshold(-38. 38,-36. 38 J·mol-1 at terminals N and C,respectively). Result: Two components in LWDH,which belong to tetracyclic triterpenoids of Alismatis Rhizoma,had lower LBEs with α-GC than ACR at terminals N and C,respectively,with hydrogen bonds and Van der Waals force as the main acting forces. Conclusion: Virtual screening based on molecular docking could help us to predict active α-GC inhibitors in LWDH,and provide scientific evidence for further studies on the mechanism of LWDH in the treatment of type 2 diabetes.
出处 《中国实验方剂学杂志》 CAS CSCD 北大核心 2018年第5期64-70,共7页 Chinese Journal of Experimental Traditional Medical Formulae
基金 江苏高校优势学科建设工程项目(PAPD) 江苏高校品牌专业建设工程项目(PPZY2015A070)
关键词 六味地黄方 虚拟筛选 Α-葡萄糖苷酶抑制剂 分子对接 2型糖尿病 Liuwei Dihuang prescription virtual screening α-glucosidase inhibitor molecular docking type 2 diabetes
  • 相关文献

参考文献15

二级参考文献304

共引文献469

同被引文献78

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部